Achievements

  • home_icon HOME
  • Research
  • Achievements
  • Paper

Total 1717, list per page:

Paper
  1. Structural insights into the oligomerization of FtsH periplasmic domain from Thermotoga maritima

    Biochemical and Biophysical Research Communications / Vol. 495(1), 1201-1207 / 2017 / Song, Ji-Joon / KIB > Cancer Metastasis Control

  2. Biophysical characterization of the basic cluster in the transcription repression domain of human MeCP2 with AT-rich DNA

    Biochemical and Biophysical Research Communications / Vol. 495(1), 145-150 / 2017 / Song, Ji-Joon / KIB > Cancer Metastasis Control

  3. Structure-based nuclear import mechanism of histones H3 and H4 mediated by Kap12

    Elife / Vol. 6 / 2017 / Song, Ji-Joon / KIB > Cancer Metastasis Control

  4. Arabidopsis FRIGIDA stimulates EFS histone H3 Lys36 methyltransferase activity

    PLANT CELL REPORTS / Vol. 36(7), 1183-1185 / 2017 / Song, Ji-Joon / KIB > Cancer Metastasis Control

  5. RNA activation-independent DNA targeting of the Type III CRISPR-Cas system by a Csm complex

    EMBO REPORTS / Vol. 18(5), 826-840 / 2017 / Song, Ji-Joon / KIB > Cancer Metastasis Control

  6. Hydrophobic Residues near the Bilin Chromophore-Binding Pocket Modulate Spectral Tuning of Insert-Cys Subfamily Cyanobacteriochromes

    Scientific Reports / Vol. 7, 40576 / 2017 / Song, Ji-Joon / KIB > Cancer Metastasis Control

  7. Structure of Full-Length SMC and Rearrangements Required for Chromosome Organization

    Molecular Cell / Vol. 67(2), 334-347 / 2017 / Oh, Byung-Ha / KIB > Cancer Metastasis Control

  8. Architecture of the type IV coupling protein complex of Legionella pneumophila

    Nature Microbiology 2 / Vol. 2, 17114 / 2017 / Oh, Byung-Ha / KIB > Cancer Metastasis Control

  9. Targeted Cancer Therapy Using Fusion Protein of TNF alpha and Tumor-Associated Fibronectin-Specific Aptide

    MOLECULAR PHARMACEUTICS / Vol. 14(11), 3772-3779 / 2017 / Jon, Sangyong / KIB > Cancer Metastasis Control

  10. Protease-activatable cell-penetrating peptide possessing ROS-triggered phase transition for enhanced cancer therapy

    JOURNAL OF CONTROLLED RELEASE / Vol. 264, 89-101 / 2017 / Jon, Sangyong / KIB > Cancer Metastasis Control

KAIST 291 Daehak-ro, Yuseong-gu, Daejeon (34141)
T : +82-42-350-2381~2384
F : +82-42-350-2080
Copyright (C) 2015. KAIST Institute